ATRA : Insider Transactions for Atara Biotherapeutics, Inc. | J3SG

Sign in:	Email	Password save:

		Company Reports
Find Symbol

Recent: Companies Filers Institutions

Membership is free, please Sign Up.

My Recent Searches

Help

Roster

Institutions

Add To Portfolo/Alerts

Get Insiders for :

Atara Biotherapeutics, Inc. (ATRA)

$0.39 0.00 (0.00%) as of 4:30 Tue 6/18

Download

Exchange:

N/A

Security Type:

N/A

Shares Out:

108,674,000

Market Cap:

42.88(M)

Last Volume:

0

Avg Vol:

0

52 Week Range:

$0.2298 - $2.31

Level I Sector:

N/A

Level II Sector:

N/A

Level III Sector:

N/A

Member Indexes:

Rankings:

Insider 3 Months : -

Insider 6 Months : -

Insider 3/6 Months : -

Guru Rank Number : 707

Guru Rank Value : 1.9

Guru Occurances : 1


6 Months 1 Year 2 Year

Company Profile Atara Biotherapeutics is engaged in T-cell immunotherapy, using its allogeneic Epstein-Barr virus (EBV) T-cell platform to develop therapies for patients with diseases, including tumors, hematologic cancers and autoimmune disease. Co.'s platform utilizes the biology of EBV T cells and has the capability to treat a range of EBV-driven diseases or other diseases through incorporation of engineered chimeric antigen receptors or T-cell receptors. Co.'s T-cell immunotherapy program, tab-cel® (tabelecleucel), is partnered with Pierre Fabre Medicament and is in Phase 3 development for patients with EBV-driven post-transplant lymphoproliferative disease.

D/I:

D is for direct shares.
I is for indirect shares.

D/I refers to the Direct or Indirect shares traded vs. held.

Forms:

A Form 4 is a form filed by an insider to indicate a change in ownership.

A Form 3 is a form filed by an insider to indicate an initial ownership of a security.

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.

Actions:

B	Buy
S	Sell
OE	Option Exercised
A	Acquired
D	Disposed
AB	Automatic Buy
AS	Automatic Sell
IO	Initial Ownership

Download:

Download only Transactions Forms. (Default)

Download only Summary Infomation.

Download both Transactions and Summary Data

Summary (Direct Transactions Only)	3 Months	6 Months	12 Months	24 Months
Total Shares Bought	0	0	816,825	816,825
Total Buy Value	$0	$0	$194,885	$194,885
Total People Bought	0	0	3	3
Total Buy Transactions	0	0	4	4
Total Shares Sold	211,204	267,396	419,842	591,605
Total Sell Value	$130,313	$170,773	$340,560	$980,941
Total People Sold	5	5	6	9
Total Sell Transactions	5	10	23	41
End Date	2024-03-28	2023-12-26	2023-06-27	2022-06-27

Adjust Filter Settings

Records found: 736

Page 22 of 30

Filer's Name

Relation Title

Off-Dir-10%

D/I

Rank

3m +/-

Form

Director

– • –

2017-01-03

4

A

$0.00

$0

D/D

2,000

19,093

-

Ciechanover Isaac E.

Chief Executive Officer

• • –

2016-12-23

4

AS

$15.25

$36,600

I/I

(2,400)

372,978

-

Ciechanover Isaac E.

Chief Executive Officer

• • –

2016-12-22

4

AS

$15.17

$36,473

I/I

(2,400)

375,378

-

Haqq Christopher

Chief Medical Officer

• – –

2016-12-15

4

AS

$15.40

$92,400

D/D

(6,000)

370,105

-

Ciechanover Isaac E.

Chief Executive Officer

• • –

2016-12-07

4

AS

$17.30

$62,280

I/I

(3,600)

377,778

-

Ciechanover Isaac E.

Chief Executive Officer

• • –

2016-12-06

4

AS

$18.55

$66,780

I/I

(3,600)

381,378

-

Ciechanover Isaac E.

Chief Executive Officer

• • –

2016-11-23

4

AS

$18.40

$67,142

I/I

(3,600)

384,978

-

Ciechanover Isaac E.

Chief Executive Officer

• • –

2016-11-22

4

AS

$18.21

$152,964

I/I

(8,400)

388,578

-

Haqq Christopher

Chief Medical Officer

• – –

2016-11-21

4

AS

$17.85

$126,164

D/D

(7,068)

376,105

-

Chief Operating Officer

• – –

2016-11-17

4

AS

$18.41

$27,247

D/D

(1,480)

230,812

-

Gallagher Carol Giltner

Director

– • –

2016-11-16

4

AS

$19.35

$22,910

D/D

(1,184)

99,010

-

Clark Mitchall G.

Chief R & QA Officer

• – –

2016-11-16

4

AS

$19.53

$58,492

D/D

(2,995)

95,187

-

Chief Operating Officer

• – –

2016-11-16

4

AS

$19.27

$137,511

D/D

(7,136)

232,292

-

Director

– • –

2016-11-15

4

OE

$0.00

$0

D/D

1,602

17,093

-

Gallagher Carol Giltner

Director

– • –

2016-11-15

4

OE

$0.00

$0

D/D

2,366

100,194

-

Ciechanover Isaac E.

Chief Executive Officer

• • –

2016-11-15

4

OE

$0.00

$0

D/D

5,908

555,044

-

Chief Financial Officer

• – –

2016-11-15

4

OE

$0.00

$0

D/D

10,503

99,826

-

Haqq Christopher

Chief Medical Officer

• – –

2016-11-15

4

AS

$19.95

$32,000

D/D

(1,604)

383,173

-

Haqq Christopher

Chief Medical Officer

• – –

2016-11-15

4

OE

$0.00

$0

D/D

829

384,777

-

Clark Mitchall G.

Chief R & QA Officer

• – –

2016-11-15

4

OE

$0.00

$0

D/D

7,212

98,182

-

Chief Operating Officer

• – –

2016-11-15

4

OE

$0.00

$0

D/D

13,761

239,428

-

Chief Operating Officer

• – –

2016-11-14

4

AS

$20.55

$196,910

D/D

(9,582)

225,667

-

Chief Financial Officer

• – –

2016-11-11

4

AS

$19.37

$48,425

D/D

(2,500)

89,323

-

Chief Financial Officer

• – –

2016-11-10

4

AS

$20.30

$50,750

D/D

(2,500)

91,823

-

Ciechanover Isaac E.

Chief Executive Officer

• • –

2016-10-27

4

AS

$13.70

$32,880

I/I

(2,400)

396,978

-

736 Records found	Previous 20 21 22 23 24 25 26 27 28 29 Next	Page 22 of 30

	Transaction Code Key:				Ownership Code Key
	B	- Buy	AB	- Automatic Buy	D	- Direct Ownership
	S	- Sell	AS	- Automatic Sell	I	- Indirect Ownership
	OE	- Options Exercised	A	- Acquired
	IO	- Initital Ownership	D	- Disposed

Copyright © 2024 j3sg.com | Disclaimer & Terms of use Products & Service About Us Contact Us

Summary:

Chart:

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.